Can serum ferritin serve as a biomarker for the prognosis of gynecological malignant tumors? A retrospective cohort study

CONCLUSION: Although this study did not find serum ferritin to be a significant independent prognosis indicator in gynecological malignant tumors, this study did identify that gynecological malignant tumor patients with high serum ferritin levels have significantly less survival time than patients with low or normal serum ferritin levels.PMID:38160345 | DOI:10.3233/CBM-230040

Source: Cancer Biomarkers - December 31, 2023 Category: Cancer & Oncology Authors: Weidan Zhang Qiaoqiao Chen Yali Cheng Miao Wang Jinfei Tong Rongrong Tang Yihong Pan Jianhua Yang Source Type: research